{"id":10649,"date":"2026-06-24T15:57:12","date_gmt":"2026-06-24T15:57:12","guid":{"rendered":"https:\/\/stoxpo.com\/?p=10649"},"modified":"2026-06-24T15:57:12","modified_gmt":"2026-06-24T15:57:12","slug":"viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/","title":{"rendered":"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Shares rise as biotech firm begins Phase 1 study of experimental therapy VK3019<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Shares of Viking Therapeutics (VKTX) moved higher after the biotechnology company announced the initiation of a Phase 1 single ascending dose clinical trial for VK3019, an important step forward in the development of its experimental drug pipeline.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The newly launched study is designed to evaluate the safety, tolerability, and pharmacokinetics of VK3019 in healthy volunteers. Phase 1 trials represent the first stage of human testing and are critical in determining whether a drug candidate is suitable for further clinical development.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Investors reacted positively to the announcement, viewing the trial initiation as a sign of continued progress in Viking&#8217;s research and development efforts. The company has attracted significant attention in recent years for its expanding portfolio of therapies targeting metabolic and endocrine disorders.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While VK3019 remains in the early stages of development, the launch of the clinical trial marks a key milestone that could pave the way for future studies and potential commercialization. As the trial advances, investors will be closely monitoring results for indications of safety and effectiveness.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shares rise as biotech firm begins Phase 1 study of experimental therapy VK3019 Shares of Viking Therapeutics (VKTX) moved higher after the biotechnology company announced the initiation of a Phase 1 single ascending dose clinical trial for VK3019, an important step forward in the development of its experimental drug pipeline. The newly launched study is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1142,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[],"footnotes":""},"categories":[308,360],"tags":[421,416,418,417,793],"coauthors":[453],"class_list":["post-10649","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-mid-cap","tag-growth","tag-movers","tag-news","tag-stock-market","tag-vktx"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Viking Therapeutics Advances Pipeline with New Clinical Trial Launch - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Shares rise as biotech firm begins Phase 1 study of experimental therapy VK3019 Shares of Viking Therapeutics (VKTX) moved higher after the biotechnology company announced the initiation of a Phase 1 single ascending dose clinical trial for VK3019, an important step forward in the development of its experimental drug pipeline. The newly launched study is [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-24T15:57:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch\",\"datePublished\":\"2026-06-24T15:57:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/\"},\"wordCount\":188,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"keywords\":[\"Growth\",\"Movers\",\"News\",\"Stock Market\",\"VKTX\"],\"articleSection\":[\"Biotechnology\",\"Mid-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/\",\"name\":\"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"datePublished\":\"2026-06-24T15:57:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-tima-miroshnichenko-9574530-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/06\\\/24\\\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/","og_locale":"en_US","og_type":"article","og_title":"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch - Stoxpo","og_description":"Shares rise as biotech firm begins Phase 1 study of experimental therapy VK3019 Shares of Viking Therapeutics (VKTX) moved higher after the biotechnology company announced the initiation of a Phase 1 single ascending dose clinical trial for VK3019, an important step forward in the development of its experimental drug pipeline. The newly launched study is [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/","og_site_name":"Stoxpo","article_published_time":"2026-06-24T15:57:12+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch","datePublished":"2026-06-24T15:57:12+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/"},"wordCount":188,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","keywords":["Growth","Movers","News","Stock Market","VKTX"],"articleSection":["Biotechnology","Mid-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/","url":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/","name":"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","datePublished":"2026-06-24T15:57:12+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-tima-miroshnichenko-9574530-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2026\/06\/24\/viking-therapeutics-advances-pipeline-with-new-clinical-trial-launch\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Viking Therapeutics Advances Pipeline with New Clinical Trial Launch"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/10649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=10649"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/10649\/revisions"}],"predecessor-version":[{"id":10650,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/10649\/revisions\/10650"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1142"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=10649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=10649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=10649"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=10649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}